Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Chronic Renal Failure

  Free Subscription

Articles published in Kidney Int

Retrieve available abstracts of 370 articles:
HTML format

Single Articles

    July 2021
  1. ESPI M, Charmetant X, Barba T, Koppe L, et al
    The ROMANOV study found impaired humoral and cellular immune responses to SARSCov-2 mRNA vaccine in virus unexposed patients receiving maintenance hemodialysis.
    Kidney Int. 2021 Jul 17. pii: S0085-2538(21)00679.
    PubMed     Abstract available

  2. BLAZQUEZ-NAVARRO A, Safi L, Meister TL, Thieme CJ, et al
    Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2 vaccinated dialysis patients.
    Kidney Int. 2021 Jul 14. pii: S0085-2538(21)00680.

  3. KAISER RA, Haller MC, Apfalter P, Kerschner H, et al
    Comparison of BNT162b2 (BioNTech/Pfizer) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients.
    Kidney Int. 2021 Jul 13. pii: S0085-2538(21)00678.

  4. SPEER C, Benning L, Tollner M, Nusshag C, et al
    Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2.
    Kidney Int. 2021 Jul 12. pii: S0085-2538(21)00676.

    Reasons for COVID-19 vaccination hesitancy in hemodialysis patients.
    Kidney Int. 2021 Jul 10. pii: S0085-2538(21)00677.

  6. LAMEIRE N, Levin A, Kellum JA, Cheung M, et al
    Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
    Kidney Int. 2021 Jul 9. pii: S0085-2538(21)00662.
    PubMed     Abstract available

  7. MUREA M, Grey CR, Lok CE
    Shared-decision making in hemodialysis vascular access practice.
    Kidney Int. 2021 Jul 8. pii: S0085-2538(21)00668.
    PubMed     Abstract available

  8. MANSOUR FA, Habib PK, El Haddad BN, Joubran NI, et al
    The Case | Bilateral submandibular swelling in a dialysis patient.
    Kidney Int. 2021;100:251-252.

  9. IKEDA Y
    Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23.
    Kidney Int. 2021;100:14-16.
    PubMed     Abstract available

    June 2021
  10. DUCLOUX D, Colladant M, Chabannes M, Yannaraki M, et al
    Humoral response after three doses of BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis.
    Kidney Int. 2021 Jun 30. pii: S0085-2538(21)00655.

  11. MEHROTRA R, Stanaway IB, Jarvik GP, Lambie M, et al
    A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysis.
    Kidney Int. 2021 Jun 28. pii: S0085-2538(21)00602.
    PubMed     Abstract available

  12. HAARHAUS M, Evenepoel P
    Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment.
    Kidney Int. 2021 Jun 5. pii: S0085-2538(21)00567.
    PubMed     Abstract available

  13. LUGTHART G, Jordans CCE, de Pagter APJ, Bresters D, et al
    Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation.
    Kidney Int. 2021 Jun 5. pii: S0085-2538(21)00579.
    PubMed     Abstract available

  14. FOLEY ED, Lombardi R, Patel V
    Hydroxycobalamin-induced pigmented effluent during dialysis.
    Kidney Int. 2021;99:1503.

  15. CHOWDHURY R, Jhamb M
    Intradialytic exercise improves left ventricular mass in hemodialysis patients.
    Kidney Int. 2021;99:1272-1274.
    PubMed     Abstract available

  16. STEVENS JS, Salazar-Schicchi J, Radhakrishnan J, Mohan S, et al
    The Case | Euglycemic ketoacidosis in a patient on continuous renal replacement therapy.
    Kidney Int. 2021;99:1507-1508.

  17. HENAUT L, Massy ZA
    Phosphate meeting cholesterol-consequences for cardiovascular disease in chronic kidney disease?
    Kidney Int. 2021;99:1264-1267.
    PubMed     Abstract available

  18. SOHN P, Narasaki Y, Rhee CM
    Intradialytic hypotension: is timing everything?
    Kidney Int. 2021;99:1269-1272.
    PubMed     Abstract available

    May 2021
  19. RODRIGUEZ-ESPINOSA D, Broseta JJ, Maduell F, Bedini JL, et al
    Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients.
    Kidney Int. 2021 May 31. pii: S0085-2538(21)00558.

  20. JOHANSEN KL, Garimella PS, Hicks CW, Kalra PA, et al
    Central and Peripheral Arterial Diseases in Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2021 May 4. pii: S0085-2538(21)00472.
    PubMed     Abstract available

  21. GLEESON S, Martin P, Bedi R, Lynch K, et al
    Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program.
    Kidney Int. 2021;99:1238-1239.

  22. THIRUNAVUKKARASU B, Nada R, Ramachandran R, Sakhuja V, et al
    Epstein-Barr virus-associated hepatic smooth muscle tumor post-renal transplant.
    Kidney Int. 2021;99:1245.

  23. DRUEKE TB, Floege J
    Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?
    Kidney Int. 2021;99:1070-1072.
    PubMed     Abstract available

    April 2021
  24. LAMBOURG E, Colvin L, Guthrie G, Murugan K, et al
    The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00458.
    PubMed     Abstract available

  25. CHEN W, Caplin N, El Shamy O, Sharma S, et al
    Use of Peritoneal Dialysis for Acute Kidney Injury during the COVID-19 Pandemic in New York City: A multicenter observational study.
    Kidney Int. 2021 Apr 27. pii: S0085-2538(21)00456.
    PubMed     Abstract available

  26. BILLANY RE, Selvaskandan H, Adenwalla SF, Hull KL, et al
    Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms.
    Kidney Int. 2021 Apr 20. pii: S0085-2538(21)00392.

  27. TORREGGIANI M, Blanchi S, Fois A, Fessi H, et al
    Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA Covid-19 vaccine. The war is far from being won.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00395.

  28. ANFT M, Blazquez-Navarro A, Paniskaki K, Skrzypczyk S, et al
    SARS-CoV-2-reactive cellular and humoral immunity in hemodialysis population.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00394.

  29. YANAY NB, Freiman S, Shapira M, Wishahi S, et al
    Experience with SARS-COV-2 BNT162b2 mRNA vaccine in dialysis patients.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00390.

  30. ATTIAS P, Sakhi H, Rieu P, Soorkia A, et al
    Antibody response to BNT162b2 vaccine in maintenance hemodialysis patients.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00393.

  31. PEEPLES J, Byku M, Hinderliter AL, Smith SV, et al
    Sparkling myocardium in a hemodialysis patient.
    Kidney Int. 2021;99:1028.

  32. GITOMER B, Pereira R, Salusky IB, Stoneback JW, et al
    Mineral bone disease in autosomal dominant polycystic kidney disease.
    Kidney Int. 2021;99:977-985.
    PubMed     Abstract available

    March 2021
  33. HANUDEL MR, Wong S, Jung G, Qiao B, et al
    Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Kidney Int. 2021 Mar 31. pii: S0085-2538(21)00354.
    PubMed     Abstract available

  34. CLARKE CL, Prendecki M, Dhutia A, Gan J, et al
    Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.
    Kidney Int. 2021 Mar 24. pii: S0085-2538(21)00295.
    PubMed     Abstract available

  35. D'AGATA EMC, Apata IW, Booth S, Boyce JM, et al
    Kidney Int. 2021 Mar 2. pii: S0085-2538(21)00270.
    PubMed     Abstract available

  36. FOTI KE, Wang D, Chang AR, Selvin E, et al
    Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States.
    Kidney Int. 2021;99:686-695.
    PubMed     Abstract available

  37. CHEUNG AK, Chang TI, Cushman WC, Furth SL, et al
    Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
    Kidney Int. 2021;99:559-569.
    PubMed     Abstract available

  38. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
    Kidney Int. 2021;99.

  39. DUCLOUX D, Rebibou JM, Courivaud C
    Pretransplant coronary artery disease screening is still valid.
    Kidney Int. 2021;99:772.

  40. EVANS RDR, Smyth B, Levin A, Jha V, et al
    The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals.
    Kidney Int. 2021;99:551-554.

    February 2021
  41. OBJOIS T, Mary A, Brazier M, Bennis Y, et al
    Decreased monocyte calcium sensing receptor expression in patients with chronic kidney disease is associated with impaired monocyte ability to reduce vascular calcification.
    Kidney Int. 2021 Feb 26. pii: S0085-2538(21)00212.
    PubMed     Abstract available

  42. ZHOU C, He Q, Gan H, Zeng T, et al
    Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans.
    Kidney Int. 2021 Feb 22. pii: S0085-2538(21)00188.
    PubMed     Abstract available

  43. KEANE DF, Raimann JG, Zhang H, Willetts J, et al
    The time of onset of intradialytic hypotension during a hemodialysis session associates with clinical parameters and mortality.
    Kidney Int. 2021 Feb 16. pii: S0085-2538(21)00190.
    PubMed     Abstract available

  44. FRANCIS A, Baigent C, Ikizler TA, Cockwell P, et al
    The urgent need to vaccinate dialysis patients against SARS-CoV-2: A call to action.
    Kidney Int. 2021 Feb 11. pii: S0085-2538(21)00177.

  45. CANAS JJ, Starr MC, Hooks J, Arregui S, et al
    Longitudinal SARS-CoV-2 seroconversion and functional heterogeneity in a pediatric dialysis unit.
    Kidney Int. 2021;99:484-486.

  46. MAJOR RW, Burton JO
    "To take or not to take an aspirin?" The age-old question of cardiovascular disease primary prevention for people with chronic kidney disease.
    Kidney Int. 2021;99:308-310.
    PubMed     Abstract available

  47. RANKIN AJ, Mark PB
    Cardiac screening prior to renal transplantation-good intentions, rather than good evidence, dictate practice.
    Kidney Int. 2021;99:306-308.
    PubMed     Abstract available

    January 2021
  48. TORREGGIANI M, Ebikili B, Blanchi S, Piccoli GB, et al
    Two episodes of SARS-CoV-2 infection in a patient on chronic hemodialysis. A note of caution.
    Kidney Int. 2021 Jan 21. pii: S0085-2538(21)00067.

  49. THAUNAT O, Legeai C, Bastien O, Caillard S, et al
    Response to "On the need to better protect hemodialysis patients. A comment on the IMPORTANT study": one more IMPORTANT thing!
    Kidney Int. 2021 Jan 10. pii: S0085-2538(20)31527.

  50. MASSIMO T, Hafedh F, Barbara PG
    On the need to better protect hemodialysis patients. A comment on "IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)".
    Kidney Int. 2021 Jan 9. pii: S0085-2538(20)31525.

  51. URSEM SR, Heijboer AC, D'Haese PC, Behets GJ, et al
    Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney disease.
    Kidney Int. 2021 Jan 7. pii: S0085-2538(20)31549.
    PubMed     Abstract available

  52. VINSON AJ, Chong AS, Clegg D, Falk C, et al
    Kidney Int. 2021 Jan 4. pii: S0085-2538(20)31545.

    Equitable hemodialysis for undocumented immigrant patients: prioritizing patient voices in care implementation.
    Kidney Int. 2021;99:26-28.
    PubMed     Abstract available

  54. KLOMJIT N, Shah K, Herrmann SM, Lieske JC, et al
    The Case | An unusual cause of tender skin lesion in an end-stage kidney disease patient.
    Kidney Int. 2021;99:275-276.

  55. BADE N, Rizk DV
    The mystery of cherry red ultrafiltrate in continuous renal replacement therapy.
    Kidney Int. 2021;99:270.

  56. LARCHER R, Kuster N, Bargnoux AS, Klouche K, et al
    Discrepant post-filter ionized calcium concentrations by 2 common gas analyzers in continuous renal replacement therapy using regional citrate anticoagulation: another piece of the puzzle.
    Kidney Int. 2021;99:268-269.

  57. FLOEGE J, Johnson RJ
    Hyperuricemia and progression of chronic kidney disease: to treat or not to treat?
    Kidney Int. 2021;99:14-16.

  58. DINH A, McCulloch CE, Ku E
    Predicting long-term kidney allograft outcomes: pitfalls and progress.
    Kidney Int. 2021;99:24-26.
    PubMed     Abstract available

    December 2020
  59. JUNI RP, Al-Shama R, Kuster DWD, van der Velden J, et al
    Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction.
    Kidney Int. 2020 Dec 22. pii: S0085-2538(20)31532.
    PubMed     Abstract available

  60. STEL VS, de Jong RW, Kramer A, Andrusev AM, et al
    Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation and comprehensive conservative management for patients with kidney failure in Europe.
    Kidney Int. 2020 Dec 21. pii: S0085-2538(20)31529.
    PubMed     Abstract available

  61. Y-H LIN H, Chen Y, Chen YH, Ta AP, et al
    Tubular mitochondrial AKT1 is activated during ischemia reperfusion injury and has a critical role in predisposition to chronic kidney disease.
    Kidney Int. 2020 Dec 11. pii: S0085-2538(20)31408.
    PubMed     Abstract available

  62. PIERCE CB, Munoz A, Ng DK, Warady BA, et al
    Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease.
    Kidney Int. 2020 Dec 7. pii: S0085-2538(20)31419.
    PubMed     Abstract available

  63. MARTIN DE, Parsons JA, Caskey FJ, Harris DCH, et al
    Ethics of kidney care in the era of COVID-19.
    Kidney Int. 2020;98:1424-1433.
    PubMed     Abstract available

    November 2020
  64. BARBOUR SJ, Coppo R, Er L, Russo ML, et al
    Updating the International IgA Nephropathy Prediction Tool for use in children.
    Kidney Int. 2020 Nov 18. pii: S0085-2538(20)31385.
    PubMed     Abstract available

  65. HASSANEIN M, Liaqat A, Paratore DA, Vachharajani TJ, et al
    The Case | Arrhythmias in a patient with sickle cell disease on hemodialysis.
    Kidney Int. 2020;98:1357-1358.

  66. PALMER BF, Clegg DJ
    Gastrointestinal potassium binding in hemodialysis.
    Kidney Int. 2020;98:1095-1097.
    PubMed     Abstract available

  67. TURNER MP, Storey BC, Mittal S, Macanovic J, et al
    Candida crescents in a renal allograft.
    Kidney Int. 2020;98:1356.

  68. REN Q, Zhou Y, Chen G, Li X, et al
    Age-adapted definition of chronic kidney disease based on Chronic Kidney Disease Epidemiology Collaboration and full age spectrum equation.
    Kidney Int. 2020;98:1350-1352.

  69. HANNA RM, Rhee CM, Kalantar-Zadeh K
    Metformin in chronic kidney disease: a strong dose of caution.
    Kidney Int. 2020;98:1101-1105.

  70. DE BROE ME, Jouret F
    Does metformin do more benefit or harm in chronic kidney disease patients?
    Kidney Int. 2020;98:1098-1101.

    October 2020
  71. HILL GALLANT KM, Stremke ER, Trevino L, Moorthi RN, et al
    EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a Phase 1b randomized cross-over trial in hemodialysis patients.
    Kidney Int. 2020 Oct 30. pii: S0085-2538(20)31246.
    PubMed     Abstract available

  72. CERVANTES L, Tong A, Camacho C, Collings A, et al
    Patient-reported outcomes and experiences in the transition of undocumented patients from emergency to scheduled hemodialysis.
    Kidney Int. 2020 Oct 27. pii: S0085-2538(20)30936.
    PubMed     Abstract available

  73. SHLIPAK MG, Tummalapalli SL, Boulware LE, Grams ME, et al
    The Case for Early Identification and Intervention of Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2020 Oct 22. pii: S0085-2538(20)31210.
    PubMed     Abstract available

  74. HSU CM, Weiner DE
    COVID-19 in Dialysis Patients: Outlasting and Outsmarting a Pandemic.
    Kidney Int. 2020 Oct 13. pii: S0085-2538(20)31203.
    PubMed     Abstract available

  75. TAKESHITA A, Yasuma T, Nishihama K, D'Alessandro-Gabazza CN, et al
    Thrombomodulin ameliorates transforming growth factor-beta1-mediated chronic kidney disease via the G-protein coupled receptor 15/Akt signal pathway.
    Kidney Int. 2020 Oct 8. pii: S0085-2538(20)30688.
    PubMed     Abstract available

  76. FLOEGE J, Drueke TB
    Mineral and bone disorder in chronic kidney disease: pioneering studies.
    Kidney Int. 2020;98:807-811.

  77. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
    Kidney Int. 2020;98.

    September 2020
  78. JAGER KJ, Kramer A, Chesnaye NC, Couchoud C, et al
    Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.
    Kidney Int. 2020 Sep 23. pii: S0085-2538(20)31081.
    PubMed     Abstract available

  79. WOLFE R, Wetmore JB, Woods RL, McNeil JJ, et al
    Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggest aspirin did not improve outcomes in older adults with chronic kidney disease.
    Kidney Int. 2020 Sep 10. pii: S0085-2538(20)30973.
    PubMed     Abstract available

  80. CHARLTON JR, Xu Y, Wu T, deRonde KA, et al
    Magnetic resonance imaging accurately tracks kidney pathology and heterogeneity in the transition from acute kidney injury to chronic kidney disease.
    Kidney Int. 2020 Sep 8. pii: S0085-2538(20)31045.
    PubMed     Abstract available

  81. MAALOULY C, Duesberg M, Danse E, Goffin E, et al
    Soft-tissue infiltration in a peritoneal dialysis patient.
    Kidney Int. 2020;98:792.

  82. HERATH C
    Chronic interstitial nephritis of agricultural communities: continuing with the term CKDu (chronic kidney disease of unknown cause) is detrimental.
    Kidney Int. 2020;98:786.

  83. LALJI R, Francis A, Wong G, Viecelli AK, et al
    Disparities in end-stage kidney disease care for children: a global survey.
    Kidney Int. 2020;98:527-532.

  84. DRUEKE TB, Floege J
    Cardiovascular complications of chronic kidney disease: pioneering studies.
    Kidney Int. 2020;98:522-526.

  85. SCHENA FP, Anelli VW, Trotta J, Di Noia T, et al
    Development and testing of an artificial intelligence tool for predicting end stage kidney disease in patients with immunoglobulin A nephropathy.
    Kidney Int. 2020 Sep 1. pii: S0085-2538(20)30969.
    PubMed     Abstract available

    August 2020
  86. CECILE C, Florian B, Carole A, Clemence B, et al
    Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients.
    Kidney Int. 2020 Aug 25. pii: S0085-2538(20)30959.
    PubMed     Abstract available

  87. RUSH BM, Bondi CD, Stocker SD, Barry KM, et al
    Genetic or Pharmacologic Nrf2 Activation Increases Proteinuria in Chronic Kidney Disease in Mice.
    Kidney Int. 2020 Aug 17. pii: S0085-2538(20)30952.
    PubMed     Abstract available

  88. NG JH, Hirsch JS, Wanchoo R, Sachdeva M, et al
    Outcomes of patients with end-stage kidney disease hospitalized with COVID-19.
    Kidney Int. 2020 Aug 15. pii: S0085-2538(20)30945.
    PubMed     Abstract available

  89. RAYNAUD M, Aubert O, Reese PP, Bouatou Y, et al
    Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation.
    Kidney Int. 2020 Aug 8. pii: S0085-2538(20)30937.
    PubMed     Abstract available

    Dialysis: learning dialysis through computation, experimentation, and implementation.
    Kidney Int. 2020;98:246-250.

  91. CHAWKI S, Buchard A, Sakhi H, Dardim K, et al
    Treatment Impact on COVID-19 evolution in hemodialysis patients.
    Kidney Int. 2020 Aug 1. pii: S0085-2538(20)30897.

  92. AMDUR RL, Paul R, Barrows ED, Kincaid D, et al
    The potassium regulator patiromer affects serum and stool electrolytes in patients receiving hemodialysis.
    Kidney Int. 2020 Aug 1. pii: S0085-2538(20)30893.
    PubMed     Abstract available

  93. BONTHUIS M, Cuperus L, Chesnaye NC, Akman S, et al
    Results in the ESPN/ERA-EDTA Registry suggest disparities in access to kidney transplantation but little variation in graft survival of children across Europe.
    Kidney Int. 2020;98:464-475.
    PubMed     Abstract available

    July 2020
  94. MENEZ S, Moledina DG, Garg AX, Thiessen-Philbrook H, et al
    Results from the TRIBE-AKI Study found associations between post-operative blood biomarkers and risk of chronic kidney disease after cardiac surgery.
    Kidney Int. 2020 Jul 25. pii: S0085-2538(20)30831.
    PubMed     Abstract available

  95. GIANELLA FG, Prado VE, Poindexter JR, Adams-Huet B, et al
    Spot urinary citrate-to-creatinine ratio is a marker for acid-base status in chronic kidney disease.
    Kidney Int. 2020 Jul 25. pii: S0085-2538(20)30833.
    PubMed     Abstract available

  96. EGSTRAND S, Nordholm A, Morevati M, Mace ML, et al
    A molecular circadian clock operates in the parathyroid gland and is disturbed in chronic kidney disease associated bone and mineral disorder.
    Kidney Int. 2020 Jul 25. pii: S0085-2538(20)30828.
    PubMed     Abstract available

  97. PONTICELLI C, Podesta MA, Moroni G
    Hyperuricemia As a trigger of Immune Response in Hypertension and Chronic Kidney Disease.
    Kidney Int. 2020 Jul 7. pii: S0085-2538(20)30804.
    PubMed     Abstract available

  98. JONSSON AJ, Lund SH, Eriksen BO, Palsson R, et al
    The prevalence of chronic kidney disease in Iceland according to KDIGO criteria and age-adapted estimated glomerular filtration rate thresholds.
    Kidney Int. 2020 Jul 2. pii: S0085-2538(20)30716.
    PubMed     Abstract available

    June 2020
  99. EL SHAMY O, Vassalotti JA, Sharma S, Aydillo-Gomez T, et al
    Coronavirus Disease (COVID-19) hospitalized patients with acute kidney injury (AKI) treated with acute peritoneal dialysis do not have infectious PD effluent.
    Kidney Int. 2020 Jun 24. pii: S0085-2538(20)30709.

  100. PATINO E, Doty SB, Bhatia D, Meza K, et al
    Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease.
    Kidney Int. 2020 Jun 20. pii: S0085-2538(20)30691.
    PubMed     Abstract available

  101. CANDELLIER A, Goffin E
    "SARS-CoV-2 in the peritoneal waste of patients treated with peritoneal dialysis".
    Kidney Int. 2020 Jun 13. pii: S0085-2538(20)30660.

  102. KEMMNER S, Guba M, Schonermarck U, Stangl M, et al
    Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
    Kidney Int. 2020 Jun 4. pii: S0085-2538(20)30628.

  103. ELENBERG E, O'Mahony CA, Eldin KW
    Ruptured gallbladder in cystinosis renal transplant recipient.
    Kidney Int. 2020;97:1304.

    May 2020
  104. RANJIT S, Henriksen K, Dvornikov A, Delsante M, et al
    Phasor approach to autofluorescence lifetime imaging FLIM can be a quantitative biomarker of chronic renal parenchymal injury.
    Kidney Int. 2020 May 24. pii: S0085-2538(20)30261.
    PubMed     Abstract available

  105. ZHANG Z, Menon MC, Zhang W, Stahl E, et al
    Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis.
    Kidney Int. 2020 May 23. pii: S0085-2538(20)30540.
    PubMed     Abstract available

  106. CHAUVIN KJ, Blake PG, Garg AX, Weir MA, et al
    Baclofen has a risk of encephalopathy in older adults receiving dialysis.
    Kidney Int. 2020 May 22. pii: S0085-2538(20)30552.
    PubMed     Abstract available

  107. GISELLA V, Silvia D, Giuseppe G, Maria DF, et al
    SARS-CoV2 in the peritoneal waste in a patient treated with peritoneal dialysis.
    Kidney Int. 2020 May 12. pii: S0085-2538(20)30531.

  108. GOICOECHEA M, Sanchez Camara LA, Macias N, Munoz de Morales A, et al
    COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain.
    Kidney Int. 2020 May 10. pii: S0085-2538(20)30509.
    PubMed     Abstract available

  109. ALBERICI F, Delbarba E, Manenti C, Econimo L, et al
    A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection.
    Kidney Int. 2020 May 8. pii: S0085-2538(20)30508.
    PubMed     Abstract available

  110. DUDREUILH C, Kumar N, Moxham V, Hemsley C, et al
    De-isolation of COVID-19-positive hemodialysis patients in the outpatient setting: a single-center experience.
    Kidney Int. 2020 May 8. pii: S0085-2538(20)30437.

    COVID-19 in Dialysis Patients: Adding a Few More Pieces to the Puzzle.
    Kidney Int. 2020 May 7. pii: S0085-2538(20)30510.
    PubMed     Abstract available

  112. JOUBRAN NI, Mansour FA, El-Haddad BN
    The Case | Turbid effluent dialysis fluid in a peritoneal dialysis patient.
    Kidney Int. 2020;97:1065-1066.

  113. TING SW, Ger TY, Kuo G
    Cutaneous oxalosis presenting as subcutaneous nodules in a dialysis patient.
    Kidney Int. 2020;97:1063.

  114. HARTE J, Chapagain A, Sarkany RPE, Chaudhri S, et al
    The Case | Bullous eruptions in end-stage renal failure.
    Kidney Int. 2020;97:1067-1068.

    April 2020
  115. SATA Y, Burke SL, Watson AMD, Jha JC, et al
    Differential sympathetic response to lesion-induced chronic kidney disease in rabbits.
    Kidney Int. 2020 Apr 25. pii: S0085-2538(20)30435.
    PubMed     Abstract available

  116. TSUBOI Y, Ohtomo S, Ichida Y, Hagita H, et al
    EOS789, a novel pan-phosphate transporter inhibitor, is effective for the treatment of chronic kidney disease-mineral bone disorder.
    Kidney Int. 2020 Apr 23. pii: S0085-2538(20)30406.
    PubMed     Abstract available

  117. LUCE M, Barba C, Yi D, Mey A, et al
    Accumulation of natriuretic peptides is associated with protein energy wasting and activation of browning in white adipose tissue in chronic kidney disease.
    Kidney Int. 2020 Apr 23. pii: S0085-2538(20)30407.
    PubMed     Abstract available

  118. BATAILLE S, Pedinielli N, Bergounioux JP
    Could ferritin help the screening for COVID-19 in hemodialysis patients?
    Kidney Int. 2020 Apr 22. pii: S0085-2538(20)30426.

  119. KLIGER AS, Cozzolino M, Jha V, Harbert G, et al
    Managing the COVID-19 pandemic: international comparisons in dialysis patients.
    Kidney Int. 2020 Apr 14. pii: S0085-2538(20)30396.

  120. NAKAGAWA Y, Komaba H, Hamano N, Wada T, et al
    Metacarpal bone mineral density by radiographic absorptiometry predicts fracture risk in patients undergoing maintenance hemodialysis.
    Kidney Int. 2020 Apr 8. pii: S0085-2538(20)30359.
    PubMed     Abstract available

  121. FAZZINI F, Lamina C, Raschenberger J, Schultheiss UT, et al
    Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney disease.
    Kidney Int. 2020 Apr 7. pii: S0085-2538(20)30358.
    PubMed     Abstract available

  122. WYATT CM, Drueke TB
    Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease.
    Kidney Int. 2020;97:639-642.

    March 2020
  123. FLYTHE JE, Chang TI, Gallagher MP, Lindley E, et al
    Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2020 Mar 8. pii: S0085-2538(20)30231.
    PubMed     Abstract available

  124. GOODLAD C, George S, Sandoval S, Mepham S, et al
    Measurement of innate immune response biomarkers in peritoneal dialysis effluent using a rapid diagnostic point-of-care device as a diagnostic indicator of peritonitis.
    Kidney Int. 2020 Mar 6. pii: S0085-2538(20)30225.
    PubMed     Abstract available

  125. MAALOULY C, Seront B, Morelle J, Jadoul M, et al
    The Case | Severe acute hypocalcemia in a patient on hemodialysis.
    Kidney Int. 2020;97:619-620.

    February 2020
  126. WILLIAMS VR, Konvalinka A, Song X, Zhou X, et al
    Connectivity mapping of a chronic kidney disease progression signature identified lysine deacetylases as novel therapeutic targets.
    Kidney Int. 2020 Feb 19. pii: S0085-2538(20)30144.
    PubMed     Abstract available

  127. ZHU H, Liao J, Zhou X, Hong X, et al
    Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via alphavbeta6 integrin signaling.
    Kidney Int. 2020 Feb 17. pii: S0085-2538(20)30140.
    PubMed     Abstract available

  128. GRYP T, De Paepe K, Vanholder R, Kerckhof FM, et al
    Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Kidney Int. 2020 Feb 17. pii: S0085-2538(20)30142.
    PubMed     Abstract available

  129. FURUSHO T, Sohara E, Mandai S, Kikuchi H, et al
    Renal TNFalpha activates the WNK phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease.
    Kidney Int. 2020 Feb 8. pii: S0085-2538(19)31217.
    PubMed     Abstract available

  130. HUANG CF, Chiu YW, Yu ML
    Patient-centered outreach treatment toward micro-elimination of hepatitis C virus infection in hemodialysis patients.
    Kidney Int. 2020;97:421.

    January 2020
  131. LALJI R, Francis A, Johnson DW, McCulloch M, et al
    Health disparities in access to kidney replacement therapy amongst children and adolescents with end-stage kidney disease in low- and lower-middle-income countries.
    Kidney Int. 2020 Jan 9. pii: S0085-2538(19)31252.

  132. TERKER AS, de Caestecker M
    Modeling human disease: a mouse model of acute kidney injury to chronic kidney disease progression after cardiac arrest.
    Kidney Int. 2020;97:22-24.
    PubMed     Abstract available

  133. ALLAM SR, Madhrira MM, Memon IA, Tessier J, et al
    Invasive mucormycosis in a renal transplant recipient.
    Kidney Int. 2020;97:216.

    December 2019
    Coronary artery disease in chronic kidney disease: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Dec 28. pii: S0085-2538(19)31317.

    Ferric citrate: cardio- and renoprotective in chronic kidney disease?
    Kidney Int. 2019;96:1277-1279.
    PubMed     Abstract available

    November 2019
  136. LUO S, Grams ME
    Epidemiology research to foster improvement in chronic kidney disease care.
    Kidney Int. 2019 Nov 26. pii: S0085-2538(19)31151.
    PubMed     Abstract available

  137. HESSE B, Rovas A, Buscher K, Kusche-Vihrog K, et al
    Symmetric dimethylarginine in dysfunctional high-density lipoprotein mediates endothelial glycocalyx breakdown in chronic kidney disease.
    Kidney Int. 2019 Nov 13. pii: S0085-2538(19)31057.
    PubMed     Abstract available

  138. CHAN L, Beers K, Yau AA, Chauhan K, et al
    Natural language processing of electronic health records is superior to billing codes to identify symptom burden in hemodialysis patients.
    Kidney Int. 2019 Nov 9. pii: S0085-2538(19)31116.
    PubMed     Abstract available

  139. CHIANG HP, Chiu YW, Lee JJ, Hung CC, et al
    Blood pressure modifies outcomes in patients with stage 3 to 5 chronic kidney disease.
    Kidney Int. 2019 Nov 7. pii: S0085-2538(19)31114.
    PubMed     Abstract available

  140. LEON SJ, Tangri N
    The impact of epilepsy and its treatment in patients with end-stage renal disease.
    Kidney Int. 2019;96:1063-1065.
    PubMed     Abstract available

  141. SCHMIDT-LAUBER C, Buttner-Herold M, Schiffer M, Wiesener MS, et al
    Tuberculous granulomatous interstitial nephritis in a renal allograft.
    Kidney Int. 2019;96:1243.

  142. LASTER M, Pereira RC, Salusky IB
    Unraveling the osteocyte in CKD-MBD post-renal transplantation.
    Kidney Int. 2019;96:1059-1061.
    PubMed     Abstract available

    October 2019
  143. BANE O, Hectors SJ, Gordic S, Kennedy P, et al
    Multiparametric magnetic resonance imaging shows promising results to assess renal transplant dysfunction with fibrosis.
    Kidney Int. 2019 Oct 30. pii: S0085-2538(19)31038.
    PubMed     Abstract available

  144. WYATT CM, Drueke TB
    Scratching the itch: a new therapeutic target for dialysis-associated pruritus?
    Kidney Int. 2019 Oct 25. pii: S0085-2538(19)31036.

  145. KELLY DM, Rothwell PM
    Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines.
    Kidney Int. 2019 Oct 18. pii: S0085-2538(19)31020.
    PubMed     Abstract available

  146. MARWICK TH, Amann K, Bangalore S, Cavalcante JL, et al
    Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019;96:836-849.
    PubMed     Abstract available

  147. SEKAR P, West BL, Henriksen KJ, Chang A, et al
    An incidental but pathognomonic finding in renal allograft biopsy.
    Kidney Int. 2019;96:1042.

    September 2019
  148. PEDERSEN MS, Muller M, Rulicke T, Leitner N, et al
    Lymphangiogenesis in a mouse model of renal transplant rejection extends life span of the recipients.
    Kidney Int. 2019 Sep 3. pii: S0085-2538(19)30843.
    PubMed     Abstract available

  149. PONTICELLI C, Moroni G
    Is preeclampsia a risk for end-stage renal disease?
    Kidney Int. 2019;96:547-549.
    PubMed     Abstract available

  150. DAVIES SJ
    Reaching consensus on the important outcomes for peritoneal dialysis patients.
    Kidney Int. 2019;96:545-546.
    PubMed     Abstract available

    Said the glucose sensor to the insulin pump: can glycemic control be improved in hospitalized ESRD patients with diabetes mellitus?
    Kidney Int. 2019;96:540-542.
    PubMed     Abstract available

    August 2019
  152. ORLANDI PF, Huang J, Fukagawa M, Hoy W, et al
    A collaborative, individual-level analysis compared longitudinal outcomes across the International Network of Chronic Kidney Disease (iNETCKD) cohorts.
    Kidney Int. 2019 Aug 30. pii: S0085-2538(19)30837.
    PubMed     Abstract available

  153. FRANCIS C, Courbon G, Gerber C, Neuburg S, et al
    Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.
    Kidney Int. 2019 Aug 30. pii: S0085-2538(19)30842.
    PubMed     Abstract available

  154. KAMMER M, Heinzel A, Willency JA, Duffin KL, et al
    Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes.
    Kidney Int. 2019 Aug 30. pii: S0085-2538(19)30841.
    PubMed     Abstract available

  155. MALVAR A, Alberton V, Lococo B, Ferrari M, et al
    Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis.
    Kidney Int. 2019 Aug 20. pii: S0085-2538(19)30816.
    PubMed     Abstract available

  156. PATERSON MR, Geurts AM, Kriegel AJ
    miR-146b-5p has a sex-specific role in renal and cardiac pathology in a rat model of chronic kidney disease.
    Kidney Int. 2019 Aug 16. pii: S0085-2538(19)30815.
    PubMed     Abstract available

  157. PORRINI E, Diaz JM, Moreso F, Lauzurrica R, et al
    Prediabetes is a risk factor for cardiovascular disease following renal transplantation.
    Kidney Int. 2019 Aug 14. pii: S0085-2538(19)30810.
    PubMed     Abstract available

  158. MENDLEY SR, Levin A, Correa-Rotter R, Joubert BR, et al
    Chronic kidney diseases in agricultural communities: report from a workshop.
    Kidney Int. 2019 Aug 2. pii: S0085-2538(19)30781.
    PubMed     Abstract available

  159. TAN J
    Forty-billion medical expenditure for dialysis patients in China.
    Kidney Int. 2019;96:523.

  160. SEPE V, Rampino T, Libetta C
    Arterial "inflammaging" drives vascular calcification in children on dialysis.
    Kidney Int. 2019;96:522.

  161. PHILIP NM, Naranje P, Bagchi S, Das CJ, et al
    Multiple abscesses in a renal transplant recipient.
    Kidney Int. 2019;96:526.

  162. MATSUSHITA K, Saritas T, Eiwaz MB, McClellan N, et al
    The acute kidney injury to chronic kidney disease transition in a mouse model of acute cardiorenal syndrome emphasizes the role of inflammation.
    Kidney Int. 2019 Aug 1. pii: S0085-2538(19)30774.
    PubMed     Abstract available

  163. DUPONT V, Colosio C, Hureaux M, Mokri L, et al
    The Case | Severe hypertension and hyperkalemia in a kidney transplant recipient.
    Kidney Int. 2019;96:529-530.

    July 2019
  164. ALENCAR DE PINHO N, Levin A, Fukagawa M, Hoy WE, et al
    Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease.
    Kidney Int. 2019 Jul 25. pii: S0085-2538(19)30512.
    PubMed     Abstract available

  165. FAUCON AL, Flamant M, Metzger M, Boffa JJ, et al
    Extracellular fluid volume is associated with incident end-stage kidney disease and mortality in patients with chronic kidney disease.
    Kidney Int. 2019 Jul 16. pii: S0085-2538(19)30704.
    PubMed     Abstract available

  166. KAUNDAL U, Ramachandran R, Arora A, Kenwar DB, et al
    B cells: a new player in mesenchymal stromal cell-mediated immune modulation in renal transplant patients.
    Kidney Int. 2019;96:249-250.

    Chronic kidney disease and fracture risk: a mechanistic insight.
    Kidney Int. 2019;96:247.

  168. WALTHER CP, Erickson KF
    The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins.
    Kidney Int. 2019;96:22-25.
    PubMed     Abstract available

    June 2019
  169. RANGASWAMI J, Bangalore S, Kaplan B, Birdwell KA, et al
    Cardiovascular disease care fragmentation in kidney transplantation: a call for action.
    Kidney Int. 2019 Jun 10. pii: S0085-2538(19)30586.

    Depression in patients undergoing hemodialysis: time to treat.
    Kidney Int. 2019 Jun 3. pii: S0085-2538(19)30592.

  171. Wyatt CM, Drueke TB. High-dose IV iron for anemia correction in chronic kidney disease. Kidney Int. 2019;95:727-730.
    Kidney Int. 2019;95:1518.

    The Dietary Approaches to Stop Hypertension (DASH) diet in chronic kidney disease: should we embrace it?
    Kidney Int. 2019;95:1296-1298.
    PubMed     Abstract available

    May 2019
  173. DRIOLLET B, Bayer F, Chatelet V, Macher MA, et al
    Social deprivation is associated with poor kidney transplantation outcome in children.
    Kidney Int. 2019 May 28. pii: S0085-2538(19)30530.
    PubMed     Abstract available

  174. WADDY SP, Ward JB, Becerra AZ, Powers T, et al
    Epilepsy and antiseizure medications increase all-cause mortality in dialysis patients in the United States.
    Kidney Int. 2019 May 16. pii: S0085-2538(19)30514.
    PubMed     Abstract available

  175. ROSSING P, Block GA, Chin MP, Goldsberry A, et al
    Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.
    Kidney Int. 2019 May 16. pii: S0085-2538(19)30503.
    PubMed     Abstract available

  176. SISE ME, Chute DF, Oppong Y, Davis MI, et al
    Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30508.
    PubMed     Abstract available

  177. CHO ME, Hansen JL, Peters CB, Cheung AK, et al
    An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease.
    Kidney Int. 2019 May 15. pii: S0085-2538(19)30506.
    PubMed     Abstract available

  178. EGLI-SPICHTIG D, Imenez Silva PH, Glaudemans B, Gehring N, et al
    Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.
    Kidney Int. 2019 May 14. pii: S0085-2538(19)30465.
    PubMed     Abstract available

  179. COVELLA B, Vinturache AE, Cabiddu G, Attini R, et al
    A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia.
    Kidney Int. 2019 May 14. pii: S0085-2538(19)30502.
    PubMed     Abstract available

  180. FAZZINI F, Lamina C, Fendt L, Schultheiss UT, et al
    Mitochondrial DNA copy number is associated with mortality and infections in a large cohort of patients with chronic kidney disease.
    Kidney Int. 2019 May 10. pii: S0085-2538(19)30483.
    PubMed     Abstract available

  181. HALLAN SI, Rifkin DE, Potok OA, Katz R, et al
    Implementing the European Renal Best Practice Guidelines suggests that prediction equations work well to differentiate risk of end-stage renal disease vs. death in older patients with low estimated glomerular filtration rate.
    Kidney Int. 2019 May 10. pii: S0085-2538(19)30484.
    PubMed     Abstract available

  182. CHEUNG AK, Chang TI, Cushman WC, Furth SL, et al
    Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019;95:1027-1036.
    PubMed     Abstract available

  183. MAZZAFERRO S, Pasquali M
    Direct bone effects of calcimimetics in chronic kidney disease?
    Kidney Int. 2019;95:1012-1014.
    PubMed     Abstract available

  184. LEE LOY J, Koratala A, De Los Santos Y, Chamarthi G, et al
    Disseminated toxoplasmosis: a life-threatening complication of inadequate posttransplant prophylaxis.
    Kidney Int. 2019;95:1274.

  185. YU ASL, Shen C, Landsittel DP, Grantham JJ, et al
    Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.
    Kidney Int. 2019;95:1253-1261.
    PubMed     Abstract available

  186. DIAZ-TOCADOS JM, Rodriguez-Ortiz ME, Almaden Y, Pineda C, et al
    Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration.
    Kidney Int. 2019;95:1064-1078.
    PubMed     Abstract available

    April 2019
  187. HOUSE AA, Wanner C, Sarnak MJ, Pina IL, et al
    Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 30. pii: S0085-2538(19)30276.
    PubMed     Abstract available

  188. CHAN CT, Blankestijn PJ, Dember LM, Gallieni M, et al
    Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 12. pii: S0085-2538(19)30138.
    PubMed     Abstract available

  189. NASR SH, Fogo AB
    New developments in the diagnosis of fibrillary glomerulonephritis.
    Kidney Int. 2019 Apr 9. pii: S0085-2538(19)30407.
    PubMed     Abstract available

  190. JEONG JH, Biruete A, Tomayko EJ, Wu PT, et al
    Results from the randomized controlled IHOPE trial suggest no effects of oral protein supplementation and exercise training on physical function in hemodialysis patients.
    Kidney Int. 2019 Apr 2. pii: S0085-2538(19)30389.
    PubMed     Abstract available

  191. JADOUL M, Bieber BA, Martin P, Akiba T, et al
    Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.
    Kidney Int. 2019;95:939-947.
    PubMed     Abstract available

  192. ROSSIGNOL P, Frimat L, Zannad F
    The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forward.
    Kidney Int. 2019;95:747-749.
    PubMed     Abstract available

  193. HE H, Li B, Gao X, Li H, et al
    A dialysis patient with isolated persistent left superior vena cava.
    Kidney Int. 2019;95:1000.

  194. FORMAN C, Sran H, Wafi A
    Delayed stricture of irradiated iliac arteries after renal transplantation mimicking transplant renal artery stenosis.
    Kidney Int. 2019;95:999.

  195. Caplin B, Yang C-W, Anand S, et al., on behalf of International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology (i3C). The International Society of Nephrology's International Consortium o
    Kidney Int. 2019;95:997-998.

  196. LANDAU SI, Guo X, Velazquez H, Torres R, et al
    Regulated necrosis and failed repair in cisplatin-induced chronic kidney disease.
    Kidney Int. 2019;95:797-814.
    PubMed     Abstract available

  197. WYATT CM, Drueke TB
    High-dose IV iron for anemia correction in chronic kidney disease.
    Kidney Int. 2019;95:727-730.

  198. SINGH G, Swamy A, Kumari K, Brijwal M, et al
    The Case | Mass in nonfunctioning first renal allograft in a recipient of 2 transplant kidneys.
    Kidney Int. 2019;95:1001-1002.

  199. GAILLARD F, Courbebaisse M, Kamar N, Rostaing L, et al
    Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors.
    Kidney Int. 2019;95:896-904.
    PubMed     Abstract available

  200. BARBOUR S, Djurdjev O, Gill JS, Dong JJ, et al
    A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Kidney Int. 2019 Apr 1. pii: S0085-2538(19)30388.
    PubMed     Abstract available

    March 2019
  201. MANERA KE, Tong A, Craig JC, Shen J, et al
    An international Delphi survey helped develop consensus-based core outcome domains for trials in peritoneal dialysis.
    Kidney Int. 2019 Mar 29. pii: S0085-2538(19)30340.
    PubMed     Abstract available

  202. TAYLOR DM, Bradley JA, Bradley C, Draper H, et al
    Limited health literacy is associated with reduced access to kidney transplantation.
    Kidney Int. 2019 Mar 27. pii: S0085-2538(19)30049.
    PubMed     Abstract available

  203. MAYER GJ, Wanner C, Weir MR, Inzucchi SE, et al
    Analysis from the EMPA-REG OUTCOME((R)) trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics.
    Kidney Int. 2019 Mar 21. pii: S0085-2538(19)30317.
    PubMed     Abstract available

  204. AZUKAITIS K, Ju W, Kirchner M, Nair V, et al
    Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30184.
    PubMed     Abstract available

  205. BALLY L, Gubler P, Thabit H, Hartnell S, et al
    Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30322.
    PubMed     Abstract available

  206. FU R, Kim SJ, de Oliveira C, Coyte PC, et al
    An instrumental variable approach quantifies and confirms the duration of pre-transplant dialysis has negative impact on kidney transplant recipient survival.
    Kidney Int. 2019 Mar 19. pii: S0085-2538(19)30323.
    PubMed     Abstract available

  207. OTTLEWSKI I, Munch J, Wagner T, Schonauer R, et al
    Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30187.
    PubMed     Abstract available

  208. SCHLACKOW I, Kent S, Herrington W, Emberson J, et al
    Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.
    Kidney Int. 2019 Mar 12. pii: S0085-2538(19)30171.
    PubMed     Abstract available

  209. ROSSING P, Persson F, Frimodt-Moller M
    Improvements in albuminuria and chronic kidney disease progression with the appetite suppressant lorcaserin.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30281.

  210. ROWE C, Sitch AJ, Barratt J, Brettell EA, et al
    Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease.
    Kidney Int. 2019 Mar 7. pii: S0085-2538(19)30274.
    PubMed     Abstract available

  211. BAI M, Chen H, Ding D, Song R, et al
    MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30114.
    PubMed     Abstract available

  212. LOUTRADIS C, Sarafidis PA, Ekart R, Papadopoulos C, et al
    The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30270.
    PubMed     Abstract available

  213. AGARWAL AK, Haddad NJ, Vachharajani TJ, Asif A, et al
    Innovations in vascular access for hemodialysis.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30103.
    PubMed     Abstract available

  214. MULAY SR
    Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30109.
    PubMed     Abstract available

  215. BANERJEE T, Crews DC, Tuot DS, Pavkov ME, et al
    Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertension.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30113.
    PubMed     Abstract available

  216. EVENEPOEL P, Claes K, Meijers B, Laurent MR, et al
    Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30105.
    PubMed     Abstract available

  217. COMBALIA A, Munoz-Mahamud E, Cofan F
    Giant calcified mass in a hemodialysis patient.
    Kidney Int. 2019;95:719.

  218. CHAMARTHI G, Koratala A
    Embedded peritoneal dialysis catheter.
    Kidney Int. 2019;95:718.

  219. GORAYA N, Simoni J, Sager LN, Madias NE, et al
    Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Kidney Int. 2019 Mar 1. pii: S0085-2538(18)30945.
    PubMed     Abstract available

  220. SRIVASTAVA P, Solanki AK, Arif E, Wolf BJ, et al
    Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.
    Kidney Int. 2019;95:708-716.
    PubMed     Abstract available

    February 2019
  221. SANCHIS P, Ho CY, Liu Y, Beltran LE, et al
    Arterial "inflammaging" drives vascular calcification in children on dialysis.
    Kidney Int. 2019 Feb 28. pii: S0085-2538(19)30035.
    PubMed     Abstract available

  222. XU H, Kuja-Halkola R, Chen X, Magnusson PKE, et al
    Higher body mass index is associated with incident diabetes and chronic kidney disease independent of genetic confounding.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30047.
    PubMed     Abstract available

  223. FRIBOURG M, Anderson L, Fischman C, Cantarelli C, et al
    T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30192.
    PubMed     Abstract available

  224. WEWERS TM, Mayer AB, Pfleiderer A, Beul K, et al
    Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
    Kidney Int. 2019 Feb 22. pii: S0085-2538(18)30901.
    PubMed     Abstract available

  225. KIKUCHI K, Hamano T, Wada A, Nakai S, et al
    Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis.
    Kidney Int. 2019 Feb 16. pii: S0085-2538(18)30897.
    PubMed     Abstract available

  226. CONNAUGHTON DM, Kennedy C, Shril S, Mann N, et al
    Monogenic causes of chronic kidney disease in adults.
    Kidney Int. 2019 Feb 12. pii: S0085-2538(18)30839.
    PubMed     Abstract available

  227. TANASIYCHUK T, Kushnir DA, Antebi A, Frajewicki V, et al
    Paradoxically normal location of peritoneal dialysis catheter.
    Kidney Int. 2019;95:470.

  228. EVENEPOEL P, Claes K, Cavalier E, Meijers B, et al
    A distinct bone phenotype in ADPKD patients with end-stage renal disease.
    Kidney Int. 2019;95:412-419.
    PubMed     Abstract available

  229. CANAUD B, Kooman J, Selby NM, Taal M, et al
    Sodium and water handling during hemodialysis: new pathophysiologic insights and management approaches for improving outcomes in end-stage kidney disease.
    Kidney Int. 2019;95:296-309.
    PubMed     Abstract available

  230. HRUSKA KA, Mahjoub MR
    New pathogenic insights inform therapeutic target development for renal osteodystrophy.
    Kidney Int. 2019;95:261-263.
    PubMed     Abstract available

  231. NUVOLONE M, Merlini G
    Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice.
    Kidney Int. 2019;95:258-260.
    PubMed     Abstract available

  232. ZHUO M, Li J, Lecker SH
    Brugada phenocopy induced by hyperkalemia.
    Kidney Int. 2019;95:471.

    January 2019
  233. HAMMER F, Malzahn U, Donhauser J, Betz C, et al
    A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients.
    Kidney Int. 2019 Jan 29. pii: S0085-2538(18)30906.
    PubMed     Abstract available

  234. CONNOLLY R, Denton MD, Humphreys H, McLoughlin RM, et al
    Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?
    Kidney Int. 2019 Jan 26. pii: S0085-2538(18)30824.
    PubMed     Abstract available

  235. VIECELLI AK, Lok CE
    Hemodialysis vascular access in the elderly-getting it right.
    Kidney Int. 2019;95:38-49.
    PubMed     Abstract available

  236. SMITH SF, Hosgood SA, Nicholson ML
    Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells.
    Kidney Int. 2019;95:50-56.
    PubMed     Abstract available

  237. CAPLIN B, Yang CW, Anand S, Levin A, et al
    The International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dat
    Kidney Int. 2019;95:4-10.

  238. CHEN Z, Zhang W, Chen X, Hsu CY, et al
    Trends in end-stage kidney disease in Shanghai, China.
    Kidney Int. 2019;95:232.

  239. WANG J, Zhang L, Zhao MH
    The authors reply.
    Kidney Int. 2019;95:233.

  240. TAKANO T, Bareke E, Takeda N, Aoudjit L, et al
    Recessive mutation in CD2AP causes focal segmental glomerulosclerosis in humans and mice.
    Kidney Int. 2019;95:57-61.
    PubMed     Abstract available

  241. SEE EJ, Jayasinghe K, Glassford N, Bailey M, et al
    Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure.
    Kidney Int. 2019;95:160-172.
    PubMed     Abstract available

    December 2018
  242. VERZOLA D, Barisione C, Picciotto D, Garibotto G, et al
    Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.
    Kidney Int. 2018 Dec 28. pii: S0085-2538(18)30777.
    PubMed     Abstract available

  243. CHAUHAN K, Verghese DA, Rao V, Chan L, et al
    Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes.
    Kidney Int. 2018 Dec 20. pii: S0085-2538(18)30772.
    PubMed     Abstract available

  244. ANGEL-KORMAN A, Stern L, Sarosiek S, Sloan JM, et al
    Long-term outcome of kidney transplantation in AL amyloidosis.
    Kidney Int. 2018 Dec 20. pii: S0085-2538(18)30774.
    PubMed     Abstract available

  245. WHITLOCK RH, Leslie WD, Shaw J, Rigatto C, et al
    The Fracture Risk Assessment Tool (FRAX(R)) predicts fracture risk in patients with chronic kidney disease.
    Kidney Int. 2018 Dec 19. pii: S0085-2538(18)30775.
    PubMed     Abstract available

  246. DEL RIO F, Andres A, Padilla M, Sanchez-Fructuoso AI, et al
    Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience.
    Kidney Int. 2018 Dec 19. pii: S0085-2538(18)30717.
    PubMed     Abstract available

  247. ERPICUM P, Weekers L, Detry O, Bonvoisin C, et al
    Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
    Kidney Int. 2018 Dec 6. pii: S0085-2538(18)30712.
    PubMed     Abstract available

  248. LIAKOPOULOS V, Eleftheriadis T, Mertens PR
    Screening for renal cell carcinoma in dialysis patients.
    Kidney Int. 2018;94:1238.

    ANCA Renal Risk Score: is prediction of end-stage renal disease at baseline possible?
    Kidney Int. 2018;94:1045-1047.
    PubMed     Abstract available

  250. SAMPATHKUMAR K, Mukuntharajan T, Rajiv A, Anandan S, et al
    Acute page kidney phenomenon following renal allograft biopsy.
    Kidney Int. 2018;94:1241.

  251. YEN TH, Wang IK, Hsu CW
    Hemoperfusion for paraquat poisoning.
    Kidney Int. 2018;94:1239.

  252. FISCHER RSB, Vangala C, Mandayam S, Chavarria D, et al
    Clinical markers to predict progression from acute to chronic kidney disease in Mesoamerican nephropathy.
    Kidney Int. 2018;94:1205-1216.
    PubMed     Abstract available

    November 2018
  253. CHARYTAN DM, Himmelfarb J, Ikizler TA, Raj DS, et al
    Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
    Kidney Int. 2018 Nov 22. pii: S0085-2538(18)30641.
    PubMed     Abstract available

  254. JOHNSON SC, Martinez F, Bitto A, Gonzalez B, et al
    mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
    Kidney Int. 2018 Nov 21. pii: S0085-2538(18)30645.
    PubMed     Abstract available

  255. KIKUCHI H, Sasaki E, Nomura N, Mori T, et al
    Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease.
    Kidney Int. 2018 Nov 13. pii: S0085-2538(18)30635.
    PubMed     Abstract available

  256. JIANG G, Luk AOY, Tam CHT, Xie F, et al
    Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30629.
    PubMed     Abstract available

  257. YAZDANI S, Callemeyn J, Gazut S, Lerut E, et al
    Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30630.
    PubMed     Abstract available

  258. BOUCHARA A, Yi D, Pastural M, Granjon S, et al
    Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients.
    Kidney Int. 2018;94:983-992.
    PubMed     Abstract available

  259. WANG T, Zhan ZP, Yang L, Lu Y, et al
    Extreme manifestations of hyperparathyroidism in a hemodialysis patient.
    Kidney Int. 2018;94:1028.

  260. SCHMITT R
    ZAG-a novel biomarker for cardiovascular risk in ESRD patients?
    Kidney Int. 2018;94:858-860.
    PubMed     Abstract available

  261. JARDINE AG, Hartmann A, Holdaas H
    Long-term renal allograft survival: a quiet revolution.
    Kidney Int. 2018;94:853-855.
    PubMed     Abstract available

  262. KRAMER H, Soyibo A, Forrester T, Boyne M, et al
    The burden of chronic kidney disease and its major risk factors in Jamaica.
    Kidney Int. 2018;94:840-842.

  263. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442-1451.
    Kidney Int. 2018;94:1025-1026.

    October 2018
  264. AGARWAL R, Tu W
    Minimally sufficient numbers of measurements for validation of 24-hour blood pressure monitoring in chronic kidney disease.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30608.
    PubMed     Abstract available

  265. BRIX SR, Noriega M, Tennstedt P, Vettorazzi E, et al
    Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
    Kidney Int. 2018 Oct 23. pii: S0085-2538(18)30552.
    PubMed     Abstract available

  266. VYCHYTIL A, Herzog R, Probst P, Ribitsch W, et al
    A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
    Kidney Int. 2018 Oct 22. pii: S0085-2538(18)30637.
    PubMed     Abstract available

  267. SANTORIELLO D, Husain SA, De Serres SA, Bomback AS, et al
    Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
    Kidney Int. 2018 Oct 2. pii: S0085-2538(18)30481.
    PubMed     Abstract available

  268. KHAN SF, Rosner MH
    "Highlighting" an unusual case of discolored peritoneal dialysis effluent.
    Kidney Int. 2018;94:835.

    Evocalcet in the management of secondary hyperparathyroidism in dialysis patients.
    Kidney Int. 2018;94:661-662.
    PubMed     Abstract available

  270. ELEFTHERIADIS T, Pissas G, Liakopoulos V, Stefanidis I, et al
    Xanthine oxidase inhibitors may prevent or slow chronic kidney disease even in the absence of hyperuricemia.
    Kidney Int. 2018;94:830-831.

  271. SELISTRE L, Rabilloud M, De Souza V, Iwaz J, et al
    Regarding "Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease".
    Kidney Int. 2018;94:827-828.

    September 2018
  272. CASPER J, Schmitz J, Brasen JH, Khalifa A, et al
    Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression.
    Kidney Int. 2018 Sep 22. pii: S0085-2538(18)30516.
    PubMed     Abstract available

  273. SHAIKH M, Woodward M, John O, Bassi A, et al
    Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India.
    Kidney Int. 2018;94:440-445.

    August 2018
  274. BLAKE PG
    Is the peritoneal dialysis biocompatibility hypothesis dead?
    Kidney Int. 2018;94:246-248.
    PubMed     Abstract available

  275. NIGWEKAR SU, Nazarian RM
    Cutaneous calcification in patients with kidney disease is not always calciphylaxis.
    Kidney Int. 2018;94:244-246.
    PubMed     Abstract available

    July 2018
  276. JHA V, Modi GK
    Getting to know the enemy better-the global burden of chronic kidney disease.
    Kidney Int. 2018 Jul 24. pii: S0085-2538(18)30362.
    PubMed     Abstract available

  277. YAMADA S, Leaf EM, Chia JJ, Cox TC, et al
    PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet.
    Kidney Int. 2018 Jul 21. pii: S0085-2538(18)30389.
    PubMed     Abstract available

  278. FUKAGAWA M, Shimazaki R, Akizawa T
    Head-to-head comparison of the new calcimimetic agent evocalcet with cinacalcet in Japanese hemodialysis patients with secondary hyperparathyroidism.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30387.
    PubMed     Abstract available

  279. XIE Y, Bowe B, Mokdad AH, Xian H, et al
    Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.
    Kidney Int. 2018 Jul 5. pii: S0085-2538(18)30318.
    PubMed     Abstract available

    The analysis of hemoglobin A1c in dialysis patients should include the variables that reflect the erythrocyte turnover.
    Kidney Int. 2018;94:220-221.

  281. RAYNER HC, Rosansky SJ
    The estimated glomerular filtration rate graph: another tool in the management of patients with advanced chronic kidney disease.
    Kidney Int. 2018;94:222.

    Protein carbamylation: a key driver of vascular calcification during chronic kidney disease.
    Kidney Int. 2018;94:12-14.
    PubMed     Abstract available

    June 2018
  283. WANNER C, Herzog CA, Turakhia MP
    Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2018 Jun 20. pii: S0085-2538(18)30358.

  284. KARABOYAS A, Xu H, Morgenstern H, Locatelli F, et al
    DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients.
    Kidney Int. 2018 Jun 13. pii: S0085-2538(18)30253.
    PubMed     Abstract available

  285. HU JR, Coresh J, Inker LA, Levey AS, et al
    Serum metabolites are associated with all-cause mortality in chronic kidney disease.
    Kidney Int. 2018 Jun 2. pii: S0085-2538(18)30247.
    PubMed     Abstract available

  286. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    PubMed     Abstract available

  287. WYATT CM, Wanner N
    Gone but not forgotten: resolution of childhood kidney disease and the risk of end-stage kidney disease in adults.
    Kidney Int. 2018;93:1260-1262.

  288. QIU C, Hanson RL, Fufaa G, Kobes S, et al
    Cytosine methylation predicts renal function decline in American Indians.
    Kidney Int. 2018;93:1417-1431.
    PubMed     Abstract available

  289. NADKARNI GN, Chauhan K, Verghese DA, Parikh CR, et al
    Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.
    Kidney Int. 2018;93:1409-1416.
    PubMed     Abstract available

    May 2018
  290. RABY AC, Gonzalez-Mateo GT, Williams A, Topley N, et al
    Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30254.
    PubMed     Abstract available

  291. DURLACHER-BETZER K, Hassan A, Levi R, Axelrod J, et al
    Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Kidney Int. 2018 May 31. pii: S0085-2538(18)30240.
    PubMed     Abstract available

  292. TAM-THAM H, Quinn RR, Weaver RG, Zhang J, et al
    Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.
    Kidney Int. 2018 May 23. pii: S0085-2538(18)30246.
    PubMed     Abstract available

  293. ALEKSOVA J, Wong P, McLachlan R, Choy KW, et al
    Sex hormone-binding globulin is a biomarker associated with nonvertebral fracture in men on dialysis therapy.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30212.
    PubMed     Abstract available

  294. SCHAEFER B, Bartosova M, Macher-Goeppinger S, Sallay P, et al
    Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.
    Kidney Int. 2018 May 15. pii: S0085-2538(18)30213.
    PubMed     Abstract available

  295. ZHU L, Guo WY, Shi SF, Liu LJ, et al
    Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30214.
    PubMed     Abstract available

  296. GUMBER R, Cohen JB, Palmer MB, Kobrin SM, et al
    A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
    Kidney Int. 2018 May 11. pii: S0085-2538(18)30211.
    PubMed     Abstract available

  297. ALRIC L, Ollivier-Hourmand I, Berard E, Hillaire S, et al
    Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30209.
    PubMed     Abstract available

  298. NG DK, Schwartz GJ, Schneider MF, Furth SL, et al
    Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease.
    Kidney Int. 2018 May 5. pii: S0085-2538(18)30184.
    PubMed     Abstract available

  299. GOODKIN DA, Bieber B
    International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation.
    Kidney Int. 2018;93:1249.

  300. FUSARO M, Cannata-Andia JB, Nickolas TL, Plebani M, et al
    Clinical relevance and future perspective of fractures in patients with chronic kidney disease.
    Kidney Int. 2018;93:1248.

  301. STENGEL B
    Uncovering real mortality trends in ESRD patients.
    Kidney Int. 2018;93:1040-1043.
    PubMed     Abstract available

  302. HOMMOS MS, Zeng C, Liu Z, Troost JP, et al
    Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment.
    Kidney Int. 2018;93:1175-1182.
    PubMed     Abstract available

    April 2018
  303. NEVEN E, Vervaet B, Brand K, Gottwald-Hostalek U, et al
    Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30174.
    PubMed     Abstract available

  304. BARUTTA F, Bruno G, Mastrocola R, Bellini S, et al
    The role of cannabinoid signaling in acute and chronic kidney diseases.
    Kidney Int. 2018 Apr 26. pii: S0085-2538(18)30140.
    PubMed     Abstract available

  305. BRUCK K, Jager KJ, Zoccali C, Bello AK, et al
    Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30096.
    PubMed     Abstract available

  306. KALRA PA, Green D, Poulikakos D
    Arrhythmia in hemodialysis patients and its relation to sudden death.
    Kidney Int. 2018;93:781-783.
    PubMed     Abstract available

  307. LABRIOLA L, Jadoul M
    Taurolidine-based lock solutions for hemodialysis catheters: the enthusiasm should be tempered.
    Kidney Int. 2018;93:1015-1016.

  308. MATHEW RO, Bangalore S, Sidhu MS, Fleg JL, et al
    Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.
    Kidney Int. 2018;93:787-788.

  309. WATERS DD, Vogt L
    Lipids, inflammation, and chronic kidney disease: a SHARP perspective.
    Kidney Int. 2018;93:784-786.
    PubMed     Abstract available

  310. PRASAD PV
    Update on renal blood oxygenation level-dependent MRI to assess intrarenal oxygenation in chronic kidney disease.
    Kidney Int. 2018;93:778-780.
    PubMed     Abstract available

  311. GRAUDAL N
    U-shaped dietary sodium-associated incidence of chronic kidney disease cautions against salt overrestriction in hypertension.
    Kidney Int. 2018;93:776-778.
    PubMed     Abstract available

  312. OOMATIA A, Dupont P, Bass P, Moochhala S, et al
    The Case | Shining a light on an unusual case of chronic kidney disease.
    Kidney Int. 2018;93:1023-1024.

  313. VACHHARAJANI TJ, Agarwal AK, Asif A
    Vascular access of last resort.
    Kidney Int. 2018;93:797-802.
    PubMed     Abstract available

    March 2018
  314. GRAMS ME, Sang Y, Ballew SH, Carrero JJ, et al
    Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.
    Kidney Int. 2018 Mar 24. pii: S0085-2538(18)30097.
    PubMed     Abstract available

  315. VERVLOET MG, van Ballegooijen AJ
    Prevention and treatment of hyperphosphatemia in chronic kidney disease.
    Kidney Int. 2018 Mar 23. pii: S0085-2538(18)30124.
    PubMed     Abstract available

  316. WANG J, Zhang L, Tang SC, Kashihara N, et al
    Disease burden and challenges of chronic kidney disease in North and East Asia.
    Kidney Int. 2018 Mar 21. pii: S0085-2538(18)30094.

  317. PUN PH, Wyatt CM
    Utility of implantable cardioverter defibrillators in chronic kidney disease.
    Kidney Int. 2018 Mar 17. pii: S0085-2538(18)30196.

  318. BATAL I, Mohan S, De Serres SA, Vasilescu ER, et al
    Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Kidney Int. 2018 Mar 13. pii: S0085-2538(18)30059.
    PubMed     Abstract available

  319. TOTH PP, Dwyer JP, Cannon CP, Colhoun HM, et al
    Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease.
    Kidney Int. 2018 Mar 8. pii: S0085-2538(18)30055.
    PubMed     Abstract available

  320. TONELLI M, Wiebe N, James MT, Klarenbach SW, et al
    A population-based cohort study defines prognoses in severe chronic kidney disease.
    Kidney Int. 2018 Mar 7. pii: S0085-2538(18)30057.
    PubMed     Abstract available

    February 2018
  321. RABBANI N, Thornalley PJ
    Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Kidney Int. 2018 Feb 22. pii: S0085-2538(18)30051.
    PubMed     Abstract available

  322. KOPP C, Linz P, Maier C, Wabel P, et al
    Elevated tissue sodium deposition in patients with type 2 diabetes on hemodialysis detected by (23)Na magnetic resonance imaging.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(17)30857.
    PubMed     Abstract available

  323. SUMIDA K, Molnar MZ, Potukuchi PK, Hassan F, et al
    Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease.
    Kidney Int. 2018 Feb 3. pii: S0085-2538(17)30893.
    PubMed     Abstract available

  324. NITSCH D
    Does dialysis modality affect the development of cognitive impairment?
    Kidney Int. 2018;93:306-308.
    PubMed     Abstract available

  325. DUSSO A, Colombo MI, Shanahan CM
    Not all vascular smooth muscle cell exosomes calcify equally in chronic kidney disease.
    Kidney Int. 2018;93:298-301.
    PubMed     Abstract available

  326. ORDUNEZ P, Hoy WE
    Case definitions and approaches for surveillance of chronic kidney disease in agricultural communities in Central America: policy implications.
    Kidney Int. 2018;93:284-287.

    January 2018
  327. STOREY BC, Staplin N, Harper CH, Haynes R, et al
    Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
    Kidney Int. 2018 Jan 30. pii: S0085-2538(17)30856.
    PubMed     Abstract available

  328. ROY-CHAUDHURY P, Tumlin JA, Koplan BA, Costea AI, et al
    Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle.
    Kidney Int. 2018 Jan 27. pii: S0085-2538(17)30855.
    PubMed     Abstract available

  329. DOU L, Poitevin S, Sallee M, Addi T, et al
    Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Kidney Int. 2018 Jan 22. pii: S0085-2538(17)30826.
    PubMed     Abstract available

  330. LIU BC, Tang TT, Lv LL, Lan HY, et al
    Renal tubule injury: a driving force toward chronic kidney disease.
    Kidney Int. 2018 Jan 17. pii: S0085-2538(17)30819.
    PubMed     Abstract available

  331. PRUIJM M, Milani B, Pivin E, Podhajska A, et al
    Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30800.
    PubMed     Abstract available

  332. LEE BJ, Go AS, Parikh R, Leong TK, et al
    Pre-admission proteinuria impacts risk of non-recovery after dialysis-requiring acute kidney injury.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30797.
    PubMed     Abstract available

  333. BOMBACK AS, Santoriello D, Avasare RS, Regunathan-Shenk R, et al
    C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Kidney Int. 2018 Jan 6. pii: S0085-2538(17)30802.
    PubMed     Abstract available

  334. PERSSON F, Borg R
    YKL-40 in dialysis patients: another candidate in the quest for useful biomarkers in nephrology.
    Kidney Int. 2018;93:21-22.
    PubMed     Abstract available

    Intensive hemodialysis-keeping the faith.
    Kidney Int. 2018;93:10-12.
    PubMed     Abstract available

  336. RODELO-HAAD C, Aguera ML, Ortega R, Martinez-Lopez A, et al
    Lithium-associated nephropathy in the renal allograft.
    Kidney Int. 2018;93:273.

  337. ETTA PK, Rao MV
    Gas in a renal allograft: think beyond!
    Kidney Int. 2018;93:272.

  338. FARRAH TE, Anand A, Miller-Hodges E, Mills NL, et al
    Endothelin antagonism reduces circulating galectin-3 in patients with proteinuric chronic kidney disease.
    Kidney Int. 2018;93:270.

  339. CHEN Z, Li J, Yang Y, Li H, et al
    The renal artery is involved in Chinese Takayasu's arteritis patients.
    Kidney Int. 2018;93:245-251.
    PubMed     Abstract available

  340. TENNANKORE KK, Na Y, Wald R, Chan CT, et al
    Short daily-, nocturnal- and conventional-home hemodialysis have similar patient and treatment survival.
    Kidney Int. 2018;93:188-194.
    PubMed     Abstract available

    December 2017
  341. YU ASL, Shen C, Landsittel DP, Harris PC, et al
    Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
    Kidney Int. 2017 Dec 28. pii: S0085-2538(17)30785.
    PubMed     Abstract available

  342. ANDERS HJ, Suarez-Alvarez B, Grigorescu M, Foresto-Neto O, et al
    The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.
    Kidney Int. 2017 Dec 11. pii: S0085-2538(17)30772.
    PubMed     Abstract available

  343. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    PubMed     Abstract available

  344. Moradi H, Said HM. Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients. Kidney Int. 2016;90:252-254.
    Kidney Int. 2017;92:1558.

  345. Li L, Lai EY, Luo Z, et al. Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease. Kidney Int. 2017;92:625-633.
    Kidney Int. 2017;92:1558.

  346. Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters. Kidney Int. 2017;92:26-36.
    Kidney Int. 2017;92:1558.

  347. ISAKA Y
    Adaptor protein is a new therapeutic target in chronic kidney disease.
    Kidney Int. 2017;92:1312-1314.
    PubMed     Abstract available

    November 2017
  348. YOON CY, Noh J, Lee J, Kee YK, et al
    High and low sodium intakes are associated with incident chronic kidney disease in patients with normal renal function and hypertension.
    Kidney Int. 2017 Nov 29. pii: S0085-2538(17)30764.
    PubMed     Abstract available

    Does elastin deficiency cause chronic kidney disease?
    Kidney Int. 2017;92:1036-1038.
    PubMed     Abstract available

  350. LIN TY, Peng CH, Hung SC, Tarng DC, et al
    Body composition is associated with clinical outcomes in patients with non-dialysis-dependent chronic kidney disease.
    Kidney Int. 2017 Nov 1. pii: S0085-2538(17)30663.
    PubMed     Abstract available

    October 2017
  351. SAWINSKI D, Forde KA, Locke JE, Cohen JB, et al
    Race but not Hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice.
    Kidney Int. 2017 Oct 26. pii: S0085-2538(17)30612.
    PubMed     Abstract available

  352. NEUMANN D, Mau W, Wienke A, Girndt M, et al
    Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course.
    Kidney Int. 2017 Oct 14. pii: S0085-2538(17)30568.
    PubMed     Abstract available

  353. CHARYTAN DM, Skali H, Shah NR, Veeranna V, et al
    Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.
    Kidney Int. 2017 Oct 13. pii: S0085-2538(17)30571.
    PubMed     Abstract available

  354. TURNER JM, Peixoto AJ
    Blood pressure targets for hemodialysis patients.
    Kidney Int. 2017;92:816-823.
    PubMed     Abstract available

  355. STREJA E
    Hospital readmission for the dialysis patient: who is (not) responsible?
    Kidney Int. 2017;92:788-790.
    PubMed     Abstract available

    September 2017
  356. PIMENTEL A, Urena-Torres P, Zillikens MC, Bover J, et al
    Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Kidney Int. 2017 Sep 27. pii: S0085-2538(17)30567.
    PubMed     Abstract available

  357. LORENZ G, Schmalenberg M, Kemmner S, Haller B, et al
    Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation.
    Kidney Int. 2017 Sep 20. pii: S0085-2538(17)30540.
    PubMed     Abstract available

  358. GALVAN DL, Green NH, Danesh FR
    The hallmarks of mitochondrial dysfunction in chronic kidney disease.
    Kidney Int. 2017 Sep 8. pii: S0085-2538(17)30505.
    PubMed     Abstract available

  359. WINNICKI W, Herkner H, Lorenz M, Handisurya A, et al
    Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Kidney Int. 2017 Sep 7. pii: S0085-2538(17)30495.
    PubMed     Abstract available

    July 2017
  360. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Abstract available

    April 2017
  361. BIERZYNSKA A, McCarthy HJ, Soderquest K, Sen ES, et al
    Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
    Kidney Int. 2017;91:937-947.
    PubMed     Abstract available

    March 2017
  362. LOWENSTEIN J, Grantham JJ
    Residual renal function: a paradigm shift.
    Kidney Int. 2017;91:561-565.
    PubMed     Abstract available

  363. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    PubMed     Abstract available

    February 2017
  364. OELLGAARD J, Gaede P, Rossing P, Persson F, et al
    Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30747.
    PubMed     Abstract available

  365. TIMMERMANS SA, Abdul-Hamid MA, Vanderlocht J, Damoiseaux JG, et al
    Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30742.
    PubMed     Abstract available

  366. KU E, Lipkowitz MS, Appel LJ, Parsa A, et al
    Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Kidney Int. 2017;91:443-450.
    PubMed     Abstract available

    November 2016
  367. READY AR, Nath J, Milford DV, Adu D, et al
    Establishing sustainable kidney transplantation programs in developing world countries: a 10-year experience.
    Kidney Int. 2016;90:916-920.

    August 2016
  368. BATAL I, Crew RJ
    The Case | An 80-year-old kidney transplant recipient with malaise and early allograft dysfunction.
    Kidney Int. 2016;90:455-6.

    July 2016
  369. WETMORE JB, Guo H, Liu J, Collins AJ, et al
    The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.
    Kidney Int. 2016 Jul 14. pii: S0085-2538(16)30211.
    PubMed     Abstract available

    April 2016
  370. GILL J, Dong J, Rose C, Gill JS, et al
    The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Kidney Int. 2016 Apr 5. pii: S0085-2538(16)00324.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.